• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TLR4 激动剂 CIA05 与明矾联合增强了炭疽芽孢杆菌保护性抗原在小鼠体内的免疫应答。

A combination of the TLR4 agonist CIA05 and alum promotes the immune responses to Bacillus anthracis protective antigen in mice.

机构信息

Department of Bioscience and Biotechnology, College of Bioscience, Sejong University, 98 Kunja-dong, Kwangjin-gu, Seoul 143-747, Republic of Korea.

出版信息

Int Immunopharmacol. 2011 Sep;11(9):1195-204. doi: 10.1016/j.intimp.2011.03.020. Epub 2011 Apr 12.

DOI:10.1016/j.intimp.2011.03.020
PMID:21492746
Abstract

Anthrax is an infectious disease caused by Bacillus anthracis. The currently licensed human anthrax vaccines contain protective antigen (PA) as a major protective component and alum as an adjuvant. In this study, we investigated whether CIA05, a TLR4 agonist, is able to promote the immune response to an anthrax vaccine adjuvanted with alum. BALB/c mice were immunized intraperitoneally three times at 2-week intervals with a recombinant B. anthracis PA alone or in combination with CIA05 in the absence or presence of alum, and immune responses were determined 2 or 3 weeks after the third immunization. The results showed that the combination of CIA05 and alum significantly increased both serum anti-PA IgG antibody and toxin-neutralizing antibody titers, and the adjuvant effects were greater when lower antigen doses were used for immunization. Both CIA05 and alum stimulated PA-specific splenocyte secretion of interleukin (IL)-4, IL-5, and IL-6. A combination of the two yielded synergistic effects on IL-4 secretion, but CIA05 tended to repress IL-5 and IL-6 secretions induced by alum. Co-administration of CIA05 and alum also increased GL7 expression in B220(+)CD24(+) splenic cells, indicating the ability to activate B cells. These data suggest that CIA05, combined with alum, could be used to achieve higher immune responses to PA, leading to the development of an effective anthrax vaccine.

摘要

炭疽是由炭疽杆菌引起的传染病。目前批准的人类炭疽疫苗含有保护性抗原(PA)作为主要保护成分和明矾作为佐剂。在这项研究中,我们研究了 TLR4 激动剂 CIA05 是否能够促进对明矾佐剂炭疽疫苗的免疫反应。BALB/c 小鼠每隔 2 周通过腹膜内免疫三次重组炭疽 PA 单独或与 CIA05 联合使用,在第三次免疫后 2 或 3 周测定免疫反应。结果表明,CIA05 和明矾的联合使用显著增加了血清抗 PA IgG 抗体和毒素中和抗体滴度,并且当使用较低的抗原剂量进行免疫时,佐剂效果更大。CIA05 和明矾均刺激 PA 特异性脾细胞分泌白细胞介素(IL)-4、IL-5 和 IL-6。两者的组合对 IL-4 分泌具有协同作用,但 CIA05 倾向于抑制明矾诱导的 IL-5 和 IL-6 分泌。CIA05 和明矾的共同给药还增加了 B220(+)CD24(+)脾细胞中 GL7 的表达,表明能够激活 B 细胞。这些数据表明,CIA05 与明矾联合使用可以增强对 PA 的免疫反应,从而开发出有效的炭疽疫苗。

相似文献

1
A combination of the TLR4 agonist CIA05 and alum promotes the immune responses to Bacillus anthracis protective antigen in mice.TLR4 激动剂 CIA05 与明矾联合增强了炭疽芽孢杆菌保护性抗原在小鼠体内的免疫应答。
Int Immunopharmacol. 2011 Sep;11(9):1195-204. doi: 10.1016/j.intimp.2011.03.020. Epub 2011 Apr 12.
2
Increased long-term immunity to Bacillus anthracis protective antigen in mice immunized with a CIA06B-adjuvanted anthrax vaccine.经 CIA06B 佐剂增强的炭疽疫苗在免疫小鼠中对炭疽保护性抗原产生长效免疫。
Arch Pharm Res. 2013 Apr;36(4):464-71. doi: 10.1007/s12272-013-0034-5. Epub 2013 Feb 26.
3
Enhancement of the immune responses of mice to Bacillus anthracis protective antigen by CIA07 combined with alum.CIA07与明矾联合增强小鼠对炭疽芽孢杆菌保护性抗原的免疫反应。
Arch Pharm Res. 2008 Nov;31(11):1385-92. doi: 10.1007/s12272-001-2121-2. Epub 2008 Nov 21.
4
Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.用新型纳米乳剂重组炭疽保护性抗原疫苗进行黏膜免疫可抵御炭疽芽孢杆菌孢子攻击。
Infect Immun. 2007 Aug;75(8):4020-9. doi: 10.1128/IAI.00070-07. Epub 2007 May 14.
5
A plant based protective antigen [PA(dIV)] vaccine expressed in chloroplasts demonstrates protective immunity in mice against anthrax.叶绿体中表达的植物源性保护性抗原 [PA(dIV)] 疫苗可在小鼠中诱导针对炭疽病的保护性免疫。
Vaccine. 2011 Jun 15;29(27):4521-33. doi: 10.1016/j.vaccine.2011.03.082. Epub 2011 Apr 17.
6
Comparison of the immune responses to the CIA06-adjuvanted human papillomavirus L1 VLP vaccine with those against the licensed HPV vaccine Cervarix™ in mice.比较 CIA06 佐剂的人乳头瘤病毒 L1 VLP 疫苗与已上市的 HPV 疫苗 Cervarix™ 在小鼠中的免疫反应。
Vaccine. 2012 Jun 13;30(28):4127-34. doi: 10.1016/j.vaccine.2012.04.079. Epub 2012 May 1.
7
BA3338, a surface layer homology domain possessing protein augments immune response and protection efficacy of protective antigen against Bacillus anthracis in mouse model.BA3338,一种具有表面层同源结构域的蛋白,增强了保护性抗原针对炭疽芽孢杆菌的免疫反应和保护效力,在小鼠模型中。
J Appl Microbiol. 2020 Aug;129(2):443-452. doi: 10.1111/jam.14624. Epub 2020 Mar 18.
8
Mucosal priming of newborn mice with S. Typhi Ty21a expressing anthrax protective antigen (PA) followed by parenteral PA-boost induces B and T cell-mediated immunity that protects against infection bypassing maternal antibodies.黏膜免疫新生小鼠,用表达炭疽保护性抗原(PA)的伤寒 Ty21a 进行初始免疫,随后进行 PA 的加强免疫,可诱导 B 和 T 细胞介导的免疫,从而防止感染,且能绕过母源抗体。
Vaccine. 2010 Aug 23;28(37):6065-75. doi: 10.1016/j.vaccine.2010.06.089. Epub 2010 Jul 7.
9
Nasal immunization with anthrax protective antigen protein adjuvanted with polyriboinosinic-polyribocytidylic acid induced strong mucosal and systemic immunities.用聚肌苷酸-聚胞苷酸佐剂辅助的炭疽保护性抗原蛋白进行鼻腔免疫可诱导强烈的黏膜和全身免疫。
Pharm Res. 2006 Jun;23(6):1217-26. doi: 10.1007/s11095-006-0206-9. Epub 2006 May 25.
10
Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategy.迈向炭疽病的人类口服疫苗:基于伤寒沙门氏菌Ty21a的初免-加强免疫策略的效用。
Vaccine. 2008 Nov 11;26(48):6083-91. doi: 10.1016/j.vaccine.2008.09.010. Epub 2008 Sep 19.

引用本文的文献

1
Plant-expressed Zika virus envelope protein elicited protective immunity against the Zika virus in immunocompetent mice.植物表达的寨卡病毒包膜蛋白在免疫功能正常的小鼠中诱导产生针对寨卡病毒的保护性免疫。
Sci Rep. 2023 Dec 27;13(1):22955. doi: 10.1038/s41598-023-47428-7.
2
Advance in strategies to build efficient vaccines against tuberculosis.构建高效抗结核疫苗策略的进展
Front Vet Sci. 2022 Nov 24;9:955204. doi: 10.3389/fvets.2022.955204. eCollection 2022.
3
The Effect of a TLR4 Agonist/Cationic Liposome Adjuvant on Varicella-Zoster Virus Glycoprotein E Vaccine Efficacy: Antigen Presentation, Uptake, and Delivery to Lymph Nodes.
TLR4激动剂/阳离子脂质体佐剂对水痘-带状疱疹病毒糖蛋白E疫苗效力的影响:抗原呈递、摄取及向淋巴结的递送
Pharmaceutics. 2021 Mar 15;13(3):390. doi: 10.3390/pharmaceutics13030390.
4
Antigen-Specific IFN-γ/IL-17-Co-Producing CD4 T-Cells Are the Determinants for Protective Efficacy of Tuberculosis Subunit Vaccine.抗原特异性干扰素-γ/白细胞介素-17共产生的CD4 T细胞是结核亚单位疫苗保护效力的决定因素。
Vaccines (Basel). 2020 Jun 11;8(2):300. doi: 10.3390/vaccines8020300.
5
A De--acylated Lipooligosaccharide-Based Adjuvant System Promotes Antibody and Th1-Type Immune Responses to H1N1 Pandemic Influenza Vaccine in Mice.一种基于去酰化脂寡糖的佐剂系统促进小鼠对甲型H1N1流感大流行疫苗的抗体和Th1型免疫反应。
Biomed Res Int. 2016;2016:3713656. doi: 10.1155/2016/3713656. Epub 2016 Nov 7.
6
Characterization of the structure and immunostimulatory activity of a vaccine adjuvant, de-O-acylated lipooligosaccharide.一种疫苗佐剂——去O-酰化脂寡糖的结构及免疫刺激活性表征
PLoS One. 2014 Jan 22;9(1):e85838. doi: 10.1371/journal.pone.0085838. eCollection 2014.